Clinical Trials Directory

Trials / Completed

CompletedNCT02664909

Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
UConn Health · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

This study is a double-blinded placebo-controlled clinical trial evaluating the efficacy of 1 gram of topically applied tranexamic acid vs. saline placebo for the reduction of transfusion following hip hemiarthroplasty surgery.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic Acid
DRUGPlacebo (saline)

Timeline

Start date
2016-01-01
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2016-01-27
Last updated
2021-07-22
Results posted
2021-07-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02664909. Inclusion in this directory is not an endorsement.

Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty (NCT02664909) · Clinical Trials Directory